Results 61 to 70 of about 27,934,643 (129)

Long‐term neurodevelopmental outcomes following liver transplantation for metabolic disease‐a single centre experience

open access: yesJournal of Inherited Metabolic Disease, Volume 48, Issue 1, January 2025.
Abstract This study describes the neurodevelopmental outcome of children with urea cycle disorders (UCD) and organic acidemias (OA) preliver transplant (LT), 1‐year, and 3‐years post‐LT. We performed a retrospective chart review of children with OA or UCD transplanted between January 2014 and December 2021.
Catherine Patterson   +10 more
wiley   +1 more source

Citrullinemia stimulation test in the evaluation of the intestinal function [PDF]

open access: yes, 2013
Background: Citrullinemia is been reported as a quantitative parameter of the enterocyte mass and function. Aim: The objective of this research is to analyse the value of fasting and stimulated citrullinemias in the intestinal function evaluation ...
Veríssimo,Caria   +5 more
core  

Liver Transplantation in an Adult with Citrullinaemia Type 2

open access: yes, 2011
Citrullinaemia is a urea cycle defect that results from a deficiency of the enzyme arginosuccinate synthetase. Type 1 disease is diagnosed in childhood, whereas Type 2 disease is adult onset.
Wan-Cheng Chow   +6 more
core   +1 more source

My path to citrin deficiency

open access: yesJournal of Inherited Metabolic Disease, Volume 48, Issue 1, January 2025.
Abstract Citrin belongs to the SLC25 transport protein family found mostly in inner mitochondrial membranes. The family prototype, the ADP–ATP carrier, delivers ATP made inside mitochondria to the cellular cytoplasm and returns ADP to the mitochondrion for resynthesis of ATP.
John E. Walker
wiley   +1 more source

DataSheet1_Identification of Novel Mutations in Chinese Infants With Citrullinemia.PDF

open access: yes, 2022
Citrullinemia is a rare autosomal recessive disorder characterized by elevated concentrations of citrulline in the blood resulting from malfunction of the urea cycle. It is categorized into two types, types I and II, which are caused by argininosuccinate
Xiwen He (1485397)   +6 more
core   +1 more source

DataSheet2_Identification of Novel Mutations in Chinese Infants With Citrullinemia.docx

open access: yes, 2022
Citrullinemia is a rare autosomal recessive disorder characterized by elevated concentrations of citrulline in the blood resulting from malfunction of the urea cycle. It is categorized into two types, types I and II, which are caused by argininosuccinate
Xiwen He (1485397)   +6 more
core   +1 more source

Pathogenic rare variants in structurally stable sites.

open access: yes, 2018
A. SNV at chr9:130480398 (Residue V263) associated with a rare disease, Citrullinemia type I. The SNV locus is on a stable α-helix structure near domain binding site. B.SNV at chr7:117590378 (Residue Y569) associated with a rare disease, Cystic fibrosis.
Vasundhara Dehiya (5801795)   +2 more
core   +1 more source

Citrullinemia: clinical experience with 23 cases

open access: yes, 1998
A retrospective study was performed on the clinical outcome of 23 patients with citrullinemia diagnosed during the last 20 years in our clinic. The study group consisted of 13 patients with the neonatal form of the disease, four patients with the ...
Ayşegül Tokatlı   +2 more
core   +1 more source

Citrullinemia with an Atypical Presentation: Paroxysmal Hypoventilation Attacks.

open access: yes, 2018
Citrullinemia type 1 (CTLN1) is a rare inherited urea cycle disorder, which resulted from the deficiency of argininosuccinate synthetase enzyme. We presented an infant who was hospitalized because of acute losses of tonus and cyanotic hypoventilation ...
Arhan, Ebru   +10 more
core   +1 more source

Anesthetic Management of a Patient With Citrullinemia Type I During Dental Treatment. [PDF]

open access: yesAnesth Prog, 2021
Shibuya M   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy